Vice President of Clincial Operations @ Wilson Therapeutics (September 2014 - March 2019)
Executive Director and Head of Clinical Operations @ Oxyrane (January 2013 - August 2014)
Program Director @ Navidea Biopharmaceuticals (January 2012 - January 2013)
Regulatory Consultant @ (January 2010 - January 2011)
SVP Drug Development @ (January 2010 - December 2010)
Sr VP Drug Development @ Alseres Pharmaceuticals (June 2007 - December 2009)
Sr VP Drug Development @ Cato (April 2003 - June 2007)
VP Clinical Operations @ (January 1993 - January 2003)
Regulatory Affairs @ (January 1975 - January 1989)
Susan Flint Education
Bridgewater State University
BS (Biology/Chemistry)
Northeastern University
MS (Pharmacology)
Susan Flint Skills
Clinical Trials
Clinical Development
Drug Development
Auditing
Project Management
Regulatory Affairs
IND
GCP
CTMS
CRO
Clinical Research
Oncology
Regulatory Submissions
Clinical Operations
FDA
Biotechnology
EDC
Sop
Pharmaceutical Industry
Medical Writing
Therapeutic Areas
GMP
Regulatory Requirements
Biopharmaceuticals
Validation
Lifesciences
Protocol
Medical Affairs
Pharmacovigilance
Clinical Data Management
Pharmacology
Vaccines
Drug Discovery
21 CFR Part 11
Clinical Monitoring
ICH-GCP
Technology Transfer
GLP
Infectious Diseases
Neurology
Clinical Study Design
Cancer
eCTD
Cardiology
Toxicology
Biomarkers
Neuroscience
Immunology
Pharmacokinetics
Rare Diseases
Ich Gcp
Regulatory
Oversight
Operations
Susan Flint Summary
Susan Flint, based in Gilford, NH, US, is currently a Member Flint Associates LLC at Flint Associates LLC. Susan Flint brings experience from previous roles at Wilson Therapeutics, Oxyrane, Navidea Biopharmaceuticals and Millennium Pharmaceuticals. Susan Flint holds a BS in Biology/Chemistry @ Bridgewater State University. With a robust skill set that includes Clinical Trials, Clinical Development, Drug Development, Auditing, Project Management and more. Susan Flint has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Susan Flint?
Find contact details for 700 million professionals.